Ferrotec : Notice of the Establishment of a Joint Venture Company That Will Conduct R&D for Biological Material Measurement Utilizing Nanomagnets and Sell Products with Precision System Science Co., Ltd. picture_as
Notice of the Establishment of a Joint Venture Company That Will Conduct R&D for Biological
Material Measurement Utilizing Nanomagnets and Sell Products with Precision System
Science Co., Ltd.
Ferrotec Holdings Corporation (hereinafter "the Company"; headquartered in Chuo-ku, Tokyo) has decided to establish a joint venture company with Precision System Science Co., Ltd. (hereinafter "PSS"; headquartered in Matsudo City, Chiba Prefecture). The joint venture company will carry out R&D for biological material measurement utilizing nanomagnets by fusing PSS's magnetic material reaction control technology, systems for automating PCR tests, immune response tests, etc., and related products, and the Company's technology for producing ferrofluids, Peltier element, etc. and related products, and sell products. Details are as follows.
1. Outline of the joint venture company
(1)
Company name
PF BioLine Co., Ltd.
(2)
Address
88 Kamihongo, Matsudo City, Chiba Prefecture
(3)
Date of establishment
October 31, 2022 (scheduled)
(4)
Capital and capital reserve
Capital: 50 million yen
Capital reserve: 50 million yen
(5)
Number of authorized
10,000 shares
shares
(6)
Contribution ratio
PSS: 51%
The Company: 49%
(7)
Executive
TBD
(8)
Contents of business
R&D for biological material measurement utilizing nanomagnets and sale of
products
(9)
Account closing month
June
2. Outline of PSS
(1)
Company name
Precision System Science Co., Ltd.
(2)
Address
88 Kamihongo, Matsudo City, Chiba Prefecture
(3)
Title and name of
Hideji Tajima, Representative Director and President
representative
(4)
Contents of business
Development of in-vitro diagnostic systems, manufacturing of devices, reagents,
and consumables, and maintenance
(5)
Capital
4,643 million yen
(6)
Date of establishment
July 17, 1985
Major shareholders and
Hideji Tajima
16.67%
(7)
Hitachi High-Tech Corporation
8.36%
shareholding ratio
UNITEC, Inc.
4.34%
Relationship between
Capital relationship
Nothing is applicable.
(8)
PSS and the
Personnel relationship
Nothing is applicable.
companies/individual
Business relationship
Nothing is applicable.
3. Purposes and aim of this joint venture
PSS supports many people in leading a comfortable life, by providing a user-friendlybio-diagnostic system and utilizing the diagnostic information, and aims to grow its business by fusing the "bio-technology" and the "manufacturing," which is the specialty of Japanese enterprises, while utilizing the "automated system technology," which is its forte. The technological concept of PSS is an automated system that is "simple, compact, and easy to maintain," and under this concept, the company developed a flagship automated device for extracting DNA (deoxyribonucleic acid). The company has so far distributed over 30,000 units of this device via global enterprises as OEMs, and this device is currently used in not only the research field, but also the clinical field, including infectious diseases and DNA testing. The purpose of this joint venture is to conduct R&D of more advanced and precise systems in the biological material measurement field by fusing PSS's magnetic material reaction control technology, systems for automating PCR tests, immune response tests, etc., and related products, and the Company's core technology for producing errofluids, Peltier element, etc. We aim to establish technologies for making a definitive diagnosis for not only infectious diseases, but also difficult-to-diagnose diseases, such as cancer and
Alzheimer's disease. Through this joint venture, we will establish a foothold for launching bio-related business.
4. Future outlook
The impact on the business performance of the Company for the current fiscal year through this matter is expected to be
minor. However, we will promptly disclose relevant items as soon as they are confirmed.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Ferrotec Holdings Corporation published this content on 27 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 October 2022 08:03:04 UTC.
Ferrotec Holdings Corporation is a Japan-based company mainly engaged in the semiconductor equipment related business, the solar cell related business and the electronic devices business. The Company has three business segments. The Semiconductor Equipment Related segment is engaged in the production of metal processing products, quartz products, ceramics products and chemical vapor deposition silicon carbide (CVD-SiC) products for vacuum seal and manufacturing equipment, as well as the processing of silicon wafers and the cleaning of equipment parts. The Solar Cell Related segment is engaged in the production of silicon crystal manufacturing equipment, silicon products for solar cells, and quartz crucibles. The Electronic Device segment is engaged in the production of thermal modules, power semiconductor substrates and magnetic fluids. The Company is also engaged in the production of saw blades, machine tools and surface treatment products.
Ferrotec : Notice of the Establishment of a Joint Venture Company That Will Conduct R&D for Biological Material Measurement Utilizing Nanomagnets and Sell Products with Precision System Science Co., Ltd. picture_as
FERROTEC HOLDINGS CORPORATION 
